Skip to main content
Top
Published in: Metabolic Brain Disease 6/2020

01-08-2020 | Parkinson's Disease | Original Article

Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis

Authors: Recep Küçükdoğru, Hasan Türkez, Mehmet Enes Arslan, Özlem Özdemir Tozlu, Erdal Sönmez, Adil Mardinoğlu, Ivana Cacciatore, Antonio Di Stefano

Published in: Metabolic Brain Disease | Issue 6/2020

Login to get access

Abstract

Parkinson’s disease (PD) is one of the most aggressive neurodegenerative diseases and characterized by the loss of dopamine-sensitive neurons in the substantia nigra region of the brain. There is no any definitive treatment to completely cure PD and existing treatments can only ease the symptoms of the disease. Boron nitride nanoparticles have been extensively studied in nano-biological studies and researches showed that it can be a promising candidate for PD treatment with its biologically active unique properties. In the present study, it was aimed to investigate ameliorative effects of hexagonal boron nitride nanoparticles (hBNs) against toxicity of 1-methyl-4-phenylpyridinium (MPP+) in experimental PD model. Experimental PD model was constituted by application of MPP+ to differentiated pluripotent human embryonal carcinoma cell (Ntera-2, NT-2) culture in wide range of concentrations (0.62 to 2 mM). Neuroprotective activity of hBNs against MPP+ toxicity was determined by cell viability assays including MTT and LDH release. Oxidative alterations by hBNs application in PD cell culture model were investigated using total antioxidant capacity (TAC) and total oxidant status (TOS) tests. The impacts of hBNs and MPP+ on nuclear integrity were analyzed by Hoechst 33258 fluorescent staining method. Acetylcholinesterase (AChE) enzyme activities were determined by a colorimetric assay towards to hBNs treatment. Cell death mechanisms caused by hBNs and MPP+ exposure was investigated by flow cytometry analysis. Experimental results showed that application of hBNs increased cell viability in PD model against MPP+ application. TAS and TOS analysis were determined that antioxidant capacity elevated after hBNs applications while oxidant levels were reduced. Furthermore, flow cytometric analysis executed that MPP+ induced apoptosis was prevented significantly (p < 0.05) after application with hBNs. In a conclusion, the obtained results indicated that hBNs have a huge potential against MPP+ toxicity and can be used in PD treatment as novel neuroprotective agent and drug delivery system.
Literature
go back to reference Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Føgh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Investig J Tech Methods Pathol Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Føgh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Investig J Tech Methods Pathol
go back to reference Chung KKK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med. https://doi.org/10.1038/nm1001-1144 Chung KKK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med. https://​doi.​org/​10.​1038/​nm1001-1144
go back to reference Ciofani G, Danti S, Genchi GG, D'Alessandro D, Pellequer JL, Odorico M, Mattoli V, Giorgi M (2012) Pilot in vivo toxicological investigation of boron nitride nanotubes. Int J Nanomedicine 7:19–24CrossRef Ciofani G, Danti S, Genchi GG, D'Alessandro D, Pellequer JL, Odorico M, Mattoli V, Giorgi M (2012) Pilot in vivo toxicological investigation of boron nitride nanotubes. Int J Nanomedicine 7:19–24CrossRef
go back to reference Emsen B, Aslan A, Turkez H, et al (2018a) The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. J Cancer Res Ther 14:941. https://doi.org/10.4103/0973-1482.177218 Emsen B, Aslan A, Turkez H, et al (2018a) The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. J Cancer Res Ther 14:941. https://​doi.​org/​10.​4103/​0973-1482.​177218
go back to reference Langston JW, Langston EB, Irwin I (1984) MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurol Scand Suppl 100:49–54 Langston JW, Langston EB, Irwin I (1984) MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurol Scand Suppl 100:49–54
Metadata
Title
Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis
Authors
Recep Küçükdoğru
Hasan Türkez
Mehmet Enes Arslan
Özlem Özdemir Tozlu
Erdal Sönmez
Adil Mardinoğlu
Ivana Cacciatore
Antonio Di Stefano
Publication date
01-08-2020
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 6/2020
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-020-00559-6

Other articles of this Issue 6/2020

Metabolic Brain Disease 6/2020 Go to the issue